title: Direct oral anticoagulant drugs (DOAC).
authors.forename: Robert A
authors.initials: RA
authors.lastname: Blum
authors.forename: Dan
authors.initials: D
authors.lastname: Lindfield
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002387:Cataract Extraction; D000069604:Dabigatran / Q000008:administration & dosage / Q000009:adverse effects; D005130:Eye Hemorrhage / Q000139:chemically induced; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000009:adverse effects; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran